The footwear sourcing map has changed. Most compliance strategies haven't.

A decade ago, the footwear industry's relationship with the US market was built around one dominant sourcing country. China led. Supply chains were concentrated. And compliance frameworks were designed around that reality.

That world has quietly but fundamentally changed.

Vietnam now accounts for 37.4% of all US footwear imports, $10.5 billion over the past twelve months. China sits at 23.8%. Indonesia has grown into a $3.2 billion supplier. Cambodia and Bangladesh are expanding fast. What started as a China Plus One contingency has become a genuine multi-country sourcing reality for most brands operating in the US market today.

I don't think this shift gets talked about enough. Not the trade data itself, but what it actually means operationally for the brands and suppliers living it every day.

Every new sourcing country brings a different set of variables. Factory maturity varies. Quality systems are at different stages of development. Regulatory familiarity around US requirements, CPSIA, California Proposition 65, restricted substance compliance, is not consistent across the board. A facility in Vietnam that has been producing for major athletic brands for fifteen years operates very differently from an emerging factory in Cambodia that is still building its quality infrastructure.

The brands navigating this well share one thing in common. They didn't just redirect their existing compliance process to a new geography. They rebuilt it. They are testing materials at source. They are inspecting earlier in production rather than at the point of shipment. They are choosing suppliers based on verified capability, not assumed competence.

The brands that are struggling moved their production but carried their old assumptions with them.

The trade data also reveals something that should focus every brand's attention on timing. Peak import months, April, July and December, align tightly with seasonal retail demand cycles. That compresses testing and inspection windows significantly. There is very little room to find a problem late. The cost of a compliance failure at the point of import, or worse, in market, is always higher than the cost of getting it right earlier in the chain.

And this is before you factor in the regulatory side. For brands with exposure to both US and European markets, green claims legislation, chemical compliance and labelling obligations are all tightening at the same time. The sourcing map has shifted but the standards have not moved in the other direction.

The question I would ask any brand or importer today is straightforward. When did you last review your compliance strategy against your actual sourcing map? Not the map from three years ago. The one you are operating right now.

If those two things are not aligned, that is where the risk lives.